DAX ®13.112,02-0,26%TecDAX ®3.033,11+0,23%S&P FUTURE3.145,80+0,29%Nasdaq 100 Future8.376,50+0,15%

DGAP-Adhoc: Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19

| Quelle: Dow Jones Newsw... | Lesedauer etwa 2 min. | Text vorlesen Stop Pause Fortsetzen

DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Annual Results
Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19

23-Oct-2019 / 13:55 CET/CEST
Update of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

*Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year

Jena, October 23, 2019

As already announced on October 2, 2019, Carl Zeiss Meditec AG
(ISIN: DE0005313704) has achieved revenue of EUR 1,459 million
in fiscal year 2018/19 (past year: EUR 1,280.9 million) and has
significantly expanded EBIT[1] margin[2], exceeding the initial
forecast of 15.0% to 17.5%. Based on today's new assessment,
EBIT for fiscal year 2018/19 amounted to approx. EUR 264 million
(past year: EUR 197.1 million), leading to an EBIT margin of

Upon publication of preliminary results on October 2, 2019, the
company had anticipated a still higher EBIT margin for fiscal
year 2018/19.

The shortfall was caused by higher operating expenses in the
fourth quarter of fiscal year 2018/19, in part driven by the
already announced higher investments in the fields of Surgical
Ophthalmology and Digitalization.

Final results for fiscal year 2018/19 will be provided on
December 6, 2019.

*Contact for investors and press *
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: investors.meditec@zeiss.com

[1] Earnings before interest and taxes (also operating profit, EBIT) refers
to a key earnings figure within the Carl Zeiss Meditec Group and is
calculated in accordance with IFRS standards (see Annual Report 2017/18, p.
76 for reconciliation).
[2] Calculation: EBIT margin = EBIT / revenue (in %) (see Annual Report
2017/18, p. 76).

23-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange
EQS News ID: 894865

End of Announcement DGAP News Service

894865 23-Oct-2019 CET/CEST

(END) Dow Jones Newswires

October 23, 2019 07:55 ET ( 11:55 GMT)

Das könnte Sie auch interessieren



Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.